BBNX Beta Bionics, Inc.

NASDAQ
$16.95

Beta Bionics, Inc. (BBNX) is expected to report earnings on January 26, 2027, after the market close. The consensus earnings estimate is a loss of $0.50 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -9.4% since its last earnings release on October 27, 2026.

Beta Bionics, Inc. Missed Expectations, Lowers Guidance
Tuesday, October 27, 2026 · 4:02 PM ET
Earnings Date
4th Quarter, Dec 2026
Jan 26
Tuesday · 4:00 PM ET
Earnings Whisper
-
vs ($0.50)
Rev est $30.36M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $16.64

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Beta Bionics, Inc.

Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease.

Sector

Healthcare

Industry

Medical Appliances/Equipment

Held By 1 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.